Researchers analyzed PubMed for prospective, original, English-language studies published between 2004 and 2010 about thromboprophylaxis after TJA. There were 71 articles identified and 52 articles were industry-funded. There were 14 articles not funded by the industry and five articles that did not include information about the funding source.
The study found:
• 3.8 percent of the 52 industry-sponsored studies have unfavorable conclusions
• 21.4 percent of the 14 non-industry sponsored studies showed that prophylactic agents were not effective or safe, depending on the situation
Sign up for our FREE Orthopedic E-Weekly for more coverage like this sent to your inbox!
Related Articles on Orthopedic Surgery:
Dr. James Andrews Performs 3rd ACL Surgery for Carolina Panthers’ Thomas Davis
Orthopedic Surgeons Show Partial Knee Replacements Have Less Complications, Same Durability as Total Knee Replacements
Orthopedic Surgeons Following New Protocol for Obese Adolescent Patients
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.